Cidara Therapeutics Inc buy Vassago1
Start price
20.03.17
/
50%
€6.33
Target price
20.09.17
€6.86
Performance (%)
-1.00%
End price
20.09.17
€6.27
Summary
This prediction ended on 20.09.17 with a price of €6.27. With a performance of -1.00%, the BUY prediction by Vassago1 finished with a loss. Vassago1 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cidara Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by Vassago1 for this prediction
In the thread Cidara Therapeutics Inc diskutieren
CDTX
Nach den schwachen Daten der CD101 Phase II RADIANT Studie, wird diese nicht fortgeführt. Die Phase II STRIVE Studie ist davon nicht betroffen und könnte für positive Impulse sorgen.
(Laufzeit überschritten)
Stopped prediction by Vassago1 for Cidara Therapeutics Inc
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.62
06.10.21
06.10.21
-
06.10.22
06.10.22
-10.14%
15.10.21
15.10.21
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€2.68
04.02.20
04.02.20
€3.00
08.02.20
08.02.20
0.75%
08.02.20
08.02.20